Home › Sleep Disorders › Florida › Brandon
Sleep Disorders clinical trials in Brandon, FL
5 studies for Sleep Disorders are looking for participants at sites in and around Brandon (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
RecruitingPhase 2/3
- Brandon, Florida, Brandon
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
RecruitingPhase 3
- Alkermes Investigational Site, Brandon
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
RecruitingPhase 3
- Alkermes Investigational Site, Brandon
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
RecruitingPhase 3
- Alkermes Investigational Site, Brandon
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2/3
- Alkermes Investigational Site, Brandon
About Sleep Disorders
Getting a good sleep is vital to your health, but many Americans don't get enough. Learn about sleep disorders, treatments, and good sleep habits.
More about Sleep Disorders on MedlinePlus
Sleep Disorders trials in other cities
- San Antonio, TX6 studies
- Sugar Land, TX5 studies
- Orlando, FL5 studies
- Charlotte, NC5 studies
- Cincinnati, OH5 studies
- Macon, GA4 studies
- Austin, TX4 studies
- Atlanta, GA4 studies
- Columbia, SC4 studies
- Lansing, MI4 studies
- Miami, FL4 studies
- Phoenix, AZ3 studies
Other studies in Brandon
- Major Depressive Disorder6 studies
- Disorders of Excessive Somnolence6 studies
- High Blood Pressure5 studies
- Idiopathic Hypersomnia4 studies
- Steatotic Liver Disease4 studies
- Lupus4 studies
- Narcolepsy4 studies
- Depression3 studies
- Chronic Kidney Disease3 studies
- Heart Failure3 studies
- Cardiovascular Disease3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.